Anandamide inhibits adenylyl cyclase (AC) and thus activating the Raf-1/ERK/MAP pathway in ER+/PR+ breast cancer cells whilst THC activates the transcription factor JunD to finally execute action towards apoptosis in ER−/PR+ breast cancer cells [49, 56, 59]. The gene discussed is ASAH1; the disease is breast cancer.